Immix Biopharma, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
IMMX on Nasdaq
Industry
Pharmaceutical Preparations
Location
11400 West Olympic Blvd., Suite 200, Los Angeles, CA

Insiders trading volume in the past year

Immix Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yekaterina Chudnovsky Director, 10%+ Owner $6.9M Jun 11, 2024
Vladimir Torchilin Scientific Co-Founder $4.23M Dec 20, 2021
Sean Senn Under 10% owner $4.21M Jul 14, 2022
Ilya Rachman CEO and Chairman, Director $2.42M +$21.2K +0.88% Jun 11, 2024
Jason Hsu Director $2.02M +$338K +20.2% Aug 21, 2024
Carey Ng Director $1.94M +$18.6K +0.97% Aug 16, 2024
Gabriel Morris CFO, Director $660K +$21.3K +3.34% Jun 11, 2024
Helen C. Adams Director $372K Jun 11, 2024
Magda Marquet Director $141K Jun 11, 2024
Jane Buchan Director $47.8K Jun 11, 2024
Graham Ross CMO & Head of Clinical Dev. Dec 15, 2021

Recent Insider Transactions by Companies or Individuals for Immix Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.